Day I Friday, May 26 2023
Day II Saturday, May 27 2023
Day I Friday, May 26 2023
Day I Friday, MAY 26 2023
| Friday, MAY 26 | Topic | Name | Supported by |
| 09:00 – 09:05 | Opening and Introductory Remarks | W. Kuczyński, N. Rahman, M. Szamatowicz, S. Wołczyński | |
| 09:05 – 09:15 | Few words on the Polish Reproductive Medicine Cluster | Nafis Rahman (Finland) | |
|
Plenary Session
Chairs: W. Kuczyński, S. Wołczyński |
|||
| 09:15 – 09:45 | Opening talk from the ESHRE CHAIR: Quo vadis ART in Europe – The Differences and common strands we see | Carlos Calhaz-Jorge (Portugal) | |
| 09:45 – 10:15 | Deep endometriosis with and without colorectal involvement : role of robotic surgery | Emile Darai (France) | |
|
Session 1. New aspects in Reproductive Medicine
Chairs: R. Kurzawa, I. Szymusik |
|||
| 10:10 – 10:35 | Safety and efficacy of corifollitropin alfa (CFA) in low responders in ART | Annalisa Racca (Spain) |
 |
| 10:35 – 11:00 | 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) inhibitor for the treatment of endometriosis | Sanna Janhunen (Finland) |
|
| 11:00 – 11:25 | Efficacy and safety of follitropin alfa/lutropin alfa in ART in poor ovarian responders | Stratis Kolibianakis (Greece) |
 |
| 11:25 – 12:00 | Coffee Break | ||
|
Session 2. Oocytes and embryo
Chairs: K. Kozioł, K. Łukaszuk, J. Szamtowicz |
|||
| 12:00 – 12:25 | Oocyte freezing: a valuable clinical and social tool | Luca Gianaroli (Italy) | |
| 12:25 – 12:50 | Embryo Genome Editing | Anna Veiga (Spain) | |
|
Session 3. Future of IVF in Europe – round Table meeting Former and present Chairs of ESHRE Chairs: R. Spaczyński, N. Rahman |
|||
| 12:50 – 14:20 | 1. MAR today: The scenarios. | ||
| 1.1 How to organize an infertility prevention program for medical and social indications – Juha Tupanainen | |||
| 1.2 Basic research: a tool for the advance of ART? – Anna Veiga | |||
| 1.3 Add-ons: lab – Kersti Lundin | |||
| 1.4 Add-ons: clinic – Luca Gianaroli | |||
| 2. The ESHRE contribution. | |||
| 2.1 Insight into the proposed EU regulation – Cristina Magli | |||
| 2.2 ESHRE collaboration/support including ART registry – Carlos Calhaz-Jorge | |||
| 3. Time for Q&A from Audience and earlier received questions | |||
| 14:20 – 15:20 | Lunch | ||
|
Session 4. Reproductive Medicine advancements
Chairs: B. Banaszewska, A.Kuczyńska |
|||
| 15:20 – 15:45 | Triggering final follicular maturation- hCG, GnRH-agonist or both, when and to whom? | Raoul Orvieto (Israel) |
 |
| 15:45 – 16:10 | Subcutaneous versus vaginal progesterone for vitrified-warmed blastocyst transfer in artificial cycles | Baris Ata (Turkey) |
|
|
Session 5. Embryo, blastocyst
Chairs: G. Polak, B. Chrostowski |
|||
| 16:10 – 16:35 | Is double embryo transfer already history? | Juha Tapanainen (Finland) | |
| 16:35 – 17:00 | Debate: Blastocyst transfer or Cleavage stage transfer? | Kersti Lundin (Sweden) and Cristina Magli (Italy) | |
| 17:00 – 17:20 | Coffe Brake | ||
|
Session 6. hCG and progesterone Chairs: W. Baranowski, J. Kubiak |
|||
| 17:20 – 17:45 | Divergent Roles of Sirtuin 1 In Human Granulosa Cells | Rina Meidan (Israel) | |
| 17:45 – 18:10 | Subcutaneous adipose tissue as a therapeutic target in PCOS | Colin Duncan (UK) | |
Day II Saturday, May 27 2023
Day II Saturday, MAY 27 2023
| Saturday, MAY 27 | Topic | Name | Supported by |
|
Session 7. Medycyna translacyjna Chairs: Chairs: W. Baranowski, W.Kuczyński |
|||
| 09:00 – 09:20 | Translacyjna medycyna rozrodu | Sławomir Wołczyński | |
| 09:20 – 09:40 | Molecular mechanisms regulating the timing of the first two cell divisions of the embryo | Jacek Kubiak (France) | |
| 09:40 – 10:00 | Maternal microbiome and its role in the regulation of immune balance at the fetomaternal interface | Marek Zygmunt (German) | |
| 10:20 – 10:40 | Co nowego w przewidywaniu potencjału rozwojowego zarodków? | Katarzyna Kozioł |
 |
| 10:40 – 11:00 | Coffee Break | ||
|
Session 8. Endometrioza
Chairs: J.Szamatowicz, I. Szymusik |
|||
| 11:10 – 11:30 | Wpływ endometriozy na płodność i leczenie | Włodzimierz Baranowski |
 |
| 11:30 – 11:50 | Druga faza u pacjentek z endometrioza | Waldemar Kuczyński | |
| 11:50 – 12:10 | IVF u kobiety z endometriozą | Grzegorz Polak |
 |
| 12:10 – 12:30 | Dyskusja | ||
|
Session 9. Technologie w medycynie rozrodu
Chairs: A. Wdowiak, K. Kozioł |
|||
| 12:30 – 12:50 | USG piersi w medycynie rozrodu. Czy to w ogóle potrzebne badanie? | Paweł Guzik | |
| 12:50 – 13:10 | Czy jest miejsce dla laparoskopii i histeroskopii w nowoczesnych ART? | Jacek Doniec | |
| 13:10 – 13:30 | Rola standaryzacji badań obrazowych w IVF | Piotr Wygocki |
 |
| 13:30 – 14:30 | Lunch | ||
|
Session 10. Poznajmy się. Prezentacje młodych naukowców. 10-minutowe wystapienia Chairs: A. Kuczyńska, N. Rahman |
|||
| 14:30 – 14:50 | Novel uterine leiomyoma biomimetic models: Why 3D? | Oana Lupu | |
| 14:50 – 15:10 | Molecular insights underlying the adverse effects of bisphenol A on reproductive health | Ewelina Palak | |
| 15:10 – 15:30 | Do insulin resistance and lifestyle affect male fertility? | Adrianna Zańko | |
|
Session 11. Debata „Kim jest Twoja pacjentka?”
Michał Radwan, Iwona Szymusik, Robert Spaczyński, Katarzyna Kozioł, Beata Banaszewska, Marian Szamatowicz : |
|||
| 15:30 – 16:30 | – indywidulaizacj postępowania w medycynie rozrodu | ||
| – co wynika z badań hormonalnych | |||
| – co wynika z badań obrazowych | |||
|
Zakończenie Konferencji
Nafis Rahman, Slawomir Wołczyński, Waldermar Kuczyński |
|||